Maurie Markman, MD
The treatment paradigm of gynecologic malignancies is expanding with approved targeted agents and a greater focus on maintaining quality of life (QoL). According to Maurie Markman, MD, the field is moving in a precision-based medicine direction.
, Markman reflected on practice-changing advances during his career and discussed the future of gynecologic cancer treatment.
OncLive: You received the 2018 Giants of Cancer Care® award in Gynecologic Cancer. What are your thoughts on winning this award?
: Obviously, I have somewhat of a unique perspective on the Giants of Cancer Care®
since I had the privilege of being involved with the program from the beginning, both as chair and as a member of the committee. I'm very aware of the extraordinary effort that goes into exactly what it says: peer-nominated, peer-selected, and the awards are really meant to say, "Your peers have looked at you as having an impact in the field and on patients."
... to read the full story